Kirkland Advises SK Capital on Exclusive Negotiations to Acquire LISI Group’s Medical Division
Kirkland & Ellis is advising SK Capital Partners, a New York-based private investment firm, on entering exclusive negotiations with LISI Group (Euronext: FII) to acquire LISI Group’s Medical division. Lisi Medical is a leading MedTech CDMO focused on the production of high-precision metal components and assemblies serving global medical device original equipment manufacturers.
The transaction remains subject to the approval of the competent antitrust authorities, foreign direct investment control authorities and to the information and consultation processes of the relevant employee representative bodies in accordance with applicable laws. As such, the transaction is expected to close in the second half of 2025.
Read the transaction press release
The Kirkland team includes corporate lawyers Laurent Victor-Michel, Guillaume Nivault, Matthew Arenson, Etienne Vautier, Ophélie Nguyen, Hayley Hollender, Adam Natan and Alexei Segall; debt finance lawyers Thomas Dobleman, Kirsteen Nicol, R. Lee Discher, Kalish Mullen, Alia Akki, Georgie Bierwirth and Emma Shi; technology & IP transactions lawyers Max Harris, Aaron Lorber, Shareen Dhillon and Saif Khan; tax lawyers Benjamin Schreiner, Sonia Bouaffassa, Timothy Campany and Jon Herlin; environmental transactions lawyers James Dolphin and Carter Vella; healthcare lawyer Giselle Lai; employee benefits lawyer Jeffrey Quinn; and executive compensation lawyer Dominique Collins.
